Siemens - special events at Booth #507
Siemens Healthcare Diagnostics will showcase the combined strengths of Diagnostics Products Corporation (DPC), Bayer HealthCare Diagnostics and Dade Behring.
Siemens Healthcare Diagnostics will showcase the combined strengths of Diagnostics Products Corporation (DPC), Bayer HealthCare Diagnostics and Dade Behring.
"Hearing the sad news that breast cancer has returned can be a devastating experience for patients, especially as this means that the disease is no longer curable. Doctors also find imparting this information to women with whom they have developed a trusting relationship over the years extremely distressing. However, optimal use of available treatments will enable more women to stay cancer-free…
Fujifilm Medical Systems USA, based in Stamford, Connecticut, reports that it's CR for mammography (FCRm), a full-field digital mammography system, is now available for use in mobile mammography environments.
The next big development in biological targeted therapies for advanced breast cancer will be drugs acting via multiple mechanisms, experts told delegates attending the 1st Asian Breast Cancer conference, held in New Delhi 9-10 February.
Artiste is a linear accelerator and CT scanner combined. At the German Cancer Research Centre, a team of scientists led by Professors Wolfgang Schlegel and Uwe Oelfke of the Medical Physics in Radiation Oncology division, contributed substantially to the technical development of the Artiste platform. They report that users will be able to observe and correct the actual position, extension and…
The prosecution of two doctors and a faith healer has been ordered by the Dutch appeal court, due to their treatment of a patient who died seven years ago.
'How do you treat the HIV-positive, diabetic, schizophrenic patient presenting with chest pain? By making the necessary information available for personalised medicine'
Sectra's wide portfolio on show at the ECR this year includes a new PACS workstation, a photon-counting MicroDose Mammography system, pre-operative solutions for orthopaedic surgery and the company's full range of Enterprise Control solutions.
Breast cancer morbidity has been the leading oncology disease (21.8%) in Russia since 1996 - and since 1981 in St. Petersburg. In Moscow, the morbidity has increased 52.4% in last 14 years.
For individualised radiotherapy, high-precision delineation and characterisation of the tumour is critical. If highest radiation doses are delivered in a targeted fashion, the chance of tumour cell kill increases and tumour control probability is enhanced.
A promising mammography screening technology By Andrew Smith PhD, principal scientist at Hologic, Inc. in Bedford, Mass, is involved in research and development of digital imaging systems.
Advanced Research Technologies Inc. ("ART") announced the first sale of SoftScan® optical breast imaging system to the Sunnybrook Health Sciences Centre ('Sunnybrook") in Toronto, Canada. Sunnybrook is the first health centre to purchase a SoftScan imaging system since the Canadian company received regulatory approval for commercialization in Europe and Canada for its optical breast imaging…
A new American Cancer Society report estimates that there will be over 12 million new cancer cases and 7.6 million cancer deaths (about 20,000 cancer deaths a day) worldwide in 2007. The estimate comes from the first-ever Global Cancer Facts & Figures, the latest addition to the American Cancer Society's family of Facts & Figures publications.
Brenda Marsh reports on the country's flourishing and expanding breast screening programme
It is hoped that a new technology, digital breast tomosynthesis or 3-D mammography, will overcome three drawbacks of traditional screening mammography: discomfort with breast compression, cancer concealed within overlapping tissue and the limited number of views.
Change is occurring at a rapid rate in cancer care - in many European countries cancer services are now being provided primarily in an ambulatory or outpatient setting with subsequent change of resources. Karen Luker, Professor of Community Nursing at the Universtiy of Manchester, UK, thinks that specialist nurses should not only refresh their knowledge of existing and new therapies. As the face…
eSie Touch Elasticity Imaging, a new method in ultrasound, demonstrated by Siemens Medical Solutions in March at the European Congress of Radiology, is an adjunct to regular breast ultrasound examinations, and may provide a clinically relevant differentiation of benign and malignant tissue. Several studies have shown promising results, and suggest the method could reduce the number of unnecessary…
About 27,000 healthcare professionals from over 100 countries attended RSNA 2006. These included over 5,000 European clinicians. In addition, over 28,000 people from non-US countries manned about 750 exhibition stands.
For women (or friends and relatives of women with breast cancer),
"Come and experience the great Canadian Prairie Hospitality!" say the organisers of the 5th World Conference on Breast Cancer (WCBC), to be held in June next year in Winnipeg, Manitoba - the "cultural cradle of the nation, gateway to the Canadian west, and a meeting place for over 6,000 years," the WCBC Foundation points out.
Despite efforts in recent years to reduce the number of deaths caused by breast cancer it is still the most common cancer occurring in women. Approx. 47,500 new cases of the disease appear in Germany per year, a situation comparable with other European countries and with the USA. In 2004 alone, 17,592 women died from the sequela of a breast carcinoma (Federal Statistics Office statistics on…
Australia - The Australian Institute of Health and Welfare has reported a 26% decrease in the breast cancer mortality rate among women aged 50-69 years between 1990 and 2004.
Breast cancer is the most frequently occurring malignant tumour worldwide. Of the more than one million newly diagnosed cases each year, the incidence among women in Germany alone is more than 50,000. That means that every tenth woman is stricken by breast cancer at some point in her life. It numbers among the most frequent causes of death by cancer 1,2,3 , with the average age of onset being…
In molecular medicine - and particularly in oncology - Siemens Medical Solutions is concentrating on further development of the FDG (fluorodeoxyglucose) biomarker to improve identification of certain tumours.
USA - A steep drop in breast cancer rates between 2002 and 2003 correlates with the decline in hormone therapy use, according to research froma the American Cancer Society (ACS).